
-
Blistering Buttler leads Gujarat to IPL win over Bengaluru
-
Tesla sales slump as pressure piles on Musk
-
Amazon makes last-minute bid for TikTok: report
-
Canada Conservative leader warns Trump could break future trade deal
-
British band Muse cancels planned Istanbul gig
-
'I'll be back' vows Haaland after injury blow
-
Trump to unveil 'Liberation Day' tariffs as world braces
-
New coach Edwards adamant England can win women's cricket World Cup
-
Military confrontation 'almost inevitable' if Iran nuclear talks fail: French FM
-
US stocks advance ahead of looming Trump tariffs
-
Scramble for food aid in Myanmar city near quake epicentre
-
American Neilson Powless fools Visma to win Across Flanders
-
NATO chief says alliance with US 'there to stay'
-
Myanmar junta declares quake ceasefire as survivors plead for aid
-
American Neilson Powless fools Visma to win Around Flanders
-
Tesla first quarter sales sink amid anger over Musk politics
-
World's tiniest pacemaker is smaller than grain of rice
-
Judge dismisses corruption case against NY mayor
-
Nintendo to launch Switch 2 console on June 5
-
France Le Pen eyes 2027 vote, says swift appeal 'good news'
-
Postecoglou hopes Pochettino gets Spurs return wish
-
US, European stocks fall as looming Trump tariffs raise fears
-
Nintendo says Switch 2 console to be launched on June 5
-
France's Zemmour fined 10,000 euros over claim WWII leader 'saved' Jews
-
Le Pen ally denies planned rally a 'power play' against conviction
-
Letsile Tebogo says athletics saved him from life of crime
-
Man Utd 'on right track' despite 13th Premier League defeat: Dalot
-
Israel says expanding Gaza offensive to seize 'large areas'
-
Certain foreign firms must 'self-certify' with Trump diversity rules: US embassies
-
Deutsche Bank asset manager DWS fined 25 mn euros for 'greenwashing'
-
UK drawing up new action plan to tackle rising TB
-
Nigerian president sacks board of state oil company
-
Barca never had financial room to register Olmo: La Liga
-
Spain prosecutors to appeal ruling overturning Alves' rape conviction
-
Heathrow 'warned about power supply' days before shutdown
-
Epstein accuser Virginia Giuffre 'stable' after car crash
-
Myanmar quake survivors plead for more help
-
Greece to spend 25 bn euros in 'drastic' defence overhaul: PM
-
Maresca non-committal over Sancho's future at Chelsea
-
WHO facing $2.5-bn gap even after slashing budget: report
-
Real Madrid coach Ancelotti tells tax trial did not seek to defraud
-
Chinese tourists pine for Taiwan's return as Beijing jets surround island
-
Singapore detains teenage boy allegedly planning to kill Muslims
-
What is the 'Qatargate' scandal roiling Israel?
-
AI coming for anime but Ghibli's Miyazaki irreplaceable, son says
-
Swedish insurer drops $160 mn Tesla stake over labour rights
-
Hunger returns to Gaza as Israeli blockade forces bakeries shut
-
Rubio heads to Europe as transatlantic tensions soar
-
Like 'living in hell': Quake-hit Mandalay monastery clears away rubble
-
'Give me a break': Trump tariffs threaten Japan auto sector
RYCEF | -1.82% | 9.87 | $ | |
CMSC | -0.04% | 22.43 | $ | |
RBGPF | 0% | 68 | $ | |
SCS | 0.4% | 11.365 | $ | |
BCC | 1.71% | 100.63 | $ | |
NGG | -0.29% | 65.59 | $ | |
BP | -0.16% | 33.757 | $ | |
BTI | -2.6% | 40.057 | $ | |
GSK | -1.08% | 37.467 | $ | |
RIO | -0.96% | 59.66 | $ | |
VOD | -1.67% | 9.118 | $ | |
RELX | 0.14% | 50.74 | $ | |
JRI | -0.04% | 12.975 | $ | |
CMSD | 0.17% | 22.86 | $ | |
AZN | -0.42% | 72.298 | $ | |
BCE | -4.76% | 21.745 | $ |

Natural immunity more potent than vaccines during US Delta wave: study
During America's last surge of the coronavirus driven by the Delta variant, people who were unvaccinated but survived Covid were better protected than those who were vaccinated and not previously infected, a new study said Wednesday.
The finding is the latest to weigh in on a debate on the relative strengths of natural versus vaccine-acquired immunity against SARS-CoV-2, but comes this time with the imprimatur of the US Centers for Disease Control and Prevention (CDC).
The authors of the paper warned, however, against depending on infection as a strategy, given the higher risks to unvaccinated persons who weren't previously infected of hospitalization, long term impacts, and death, compared to vaccinated people.
Indeed, by November 30, 2021, some 131,000 residents of California and New York had died from Covid-19, the two states the paper, which used statistical modeling, was based on.
"Viruses are constantly changing, including the virus that causes Covid-19," the CDC said in a statement.
"The level of protection offered by vaccination and surviving a previous infection changed during the study period. Vaccination remains the safest strategy for protecting against Covid-19," it added.
The analysis was also carried out before the emergence of the Omicron variant, for which both vaccine and infection-derived immunity appear diminished, and before boosters were made widely available.
It used case data from 1.1 million people who tested positive in New York and California between May 30 to November 30, 2021, and used that to model inferences about the wider population.
Prior to Delta becoming dominant, vaccination conferred greater immunity than infection. But the relationship shifted when the variant became predominant in late June and July.
- Selection bias? -
By the week of October 3, vaccinated people who did not have prior Covid were three to four times (in California and New York, respectively) more likely to be infected than unvaccinated people with prior Covid.
In the weeks of October 13 to November 14, vaccinated people who did not have prior Covid in California, were around three times more likely to be hospitalized than unvaccinated people with prior Covid.
Protection was highest among those who had both vaccination and prior Covid.
The study could however be impacted by an effect known as "selection bias," since it excluded people who died, who were overwhelmingly unvaccinated.
Other research, including a notable paper from Israel in August, have also found that natural immunity was more potent than vaccines during the Delta surge.
But the US CDC had previously taken the opposite position, based on pre-Delta data.
"Further studies are needed to establish duration of protection from previous infection by variant type, severity, and symptomatology, including for the Omicron variant," the paper concluded.
L.Adams--AT